Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022

Rhea-AI Summary

Glucose Health, Inc. (OTC: GLUC) reported significant financial growth for Q3 2022, with revenues of $340,681, a 45% increase from Q3 2021. Gross profit soared to $153,789, marking a 148% rise year-over-year. The company achieved a net income of $8,091, a notable turnaround from a net loss of $133,160 in Q3 2021. Additionally, Glucose Health is preparing for a planned up-listing to the NASDAQ Capital Market, with an update expected by the week of October 31, 2022.

Positive

• Q3 2022 revenue increased by 45% to $340,681.
• Gross profit for Q3 2022 rose by 148% to $153,789.
• Achieved net income of $8,091 compared to a net loss of $133,160 in Q3 2021.
• Planned up-listing to NASDAQ Capital Market.

Negative

• None.

BENTONVILLE, AR , Oct. 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022, for the period ended September 30, 2022, posted today at OTCMarkets.com.

• Q3 2022 Revenue of $340,681 vs. $234,930 for Q3 2021 = a 45% increase.
• Q3 2022 Gross Profit of $153,789 vs. $62,032 for Q3 2021 = a 148% increase.
• Q3 2022 Net Income of $8,091 vs. Q3 2021 Net Loss of $133,160.

The Company additionally advises shareholders and interested investors that a progress report regarding its planned up-listing to the NASDAQ Capital Market® stock exchange is expected to be issued by press release, the week of October 31, 2022.

About Glucose Health, Inc. (OTC: GLUC)

By specializing in producing healthy and delicious beverages nutritionally appropriate¹ for the nation's 100+ million² pre and Type-2 diabetics, and additionally, with its planned launch of a new healthy and delicious soluble fiber infused "ready-to-drink" beverage, formulated to meet the nutritional needs of the 95% of Americans who are considered fiber deficient³, Glucose Health, Inc. is uniquely positioned among all micro-cap beverage companies in America. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.

For more GLUC news visit: www.glucosehealthinc.com
Like us on Facebook at: www.facebook.com/glucodown

¹ For citations visit www.glucodown.com/clinical-data
² National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services
³ Closing America's Fiber Intake Gap. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124841

Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

FAQ

What were Glucose Health's Q3 2022 earnings results?

Glucose Health reported Q3 2022 revenue of $340,681, a 45% increase from the prior year, along with a gross profit of $153,789 and a net income of $8,091.

Is Glucose Health planning to up-list to NASDAQ?

Yes, Glucose Health is preparing for an up-listing to the NASDAQ Capital Market, with a progress report expected by the week of October 31, 2022.

How does GLUC's financial performance compare to last year?

In Q3 2022, GLUC showed a significant improvement, with a 45% increase in revenue and a shift from a net loss of $133,160 in Q3 2021 to a net income of $8,091.